Sandu Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

39.50 -0.70 (-1.74%)Updated : 05 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	65.10	65.57	63.38	63.16
Other Net	0.12	0.38	0.27	0.01
Diluted Weighted Average Shares	0.97	0.97	0.94	0.85
Depreciation/ Amortization	0.67	0.58	0.52	0.53
Operating Income	2.09	1.71	1.97	2.34
Net Income	1.55	1.46	1.52	1.59
Income Availableto Com Excl Extra Ord	1.55	1.46	1.52	1.59
Other Operating Expenses Total	21.41	22.34	20.58	17.97
Net Income Before Taxes	2.16	2.07	2.22	2.32
Net Income After Taxes	1.55	1.46	1.52	1.59
Income Availableto Com Incl Extra Ord	1.55	1.46	1.52	1.59
Costof Revenue Total	32.10	32.57	31.19	35.74
Gross Profit	35.09	34.71	34.16	29.76
Interest Inc( Exp) Net- Non- Op Total	-0.05	-0.02	-0.02	-0.03
Unusual Expense( Income)	0.00	0.00	0.00	0.00
Diluted Net Income	1.55	1.46	1.52	1.59
DPS- Common Stock Primary Issue	0.80	0.80	0.75	0.75
Provisionfor Income Taxes	0.61	0.61	0.70	0.73
period Type	-	-	-	-
Net Income Before Extra Items	1.55	1.46	1.52	1.59
Total Revenue	67.19	67.28	65.35	65.50
period Length	12.00	12.00	12.00	12.00
Revenue	67.19	67.28	65.35	65.50
Selling/ General/ Admin Expenses Total	10.92	10.07	11.10	8.91
Diluted Normalized EPS	1.60	1.51	1.61	1.87
Diluted EPS Excluding Extra Ord Items	1.60	1.51	1.61	1.87
Total Adjustmentsto Net Income	-	0.00	-	0.00